Table 3. Overall survival analysis based on prior cisplatin administration – original ITT population – November 2006 cutoff date.

	VFL+BSC arm	BSC arm
	Median OS (95% CI) (months)	Median OS (95% CI) (months)	Hazard ratio (95% CI)
Patients with prior Cisplatin	N=170 6.9 (5.7–8.0)	N=91 5.3 (4.3–8.2)	0.91 (0.69–1.20)
Patients without prior Cisplatin	N=83 6.0 (4.6–8.7)	N=26 3.7 (3.1–7.1)	0.75 (0.47–1.21)

Abbreviations: BSC=best supportive care; OS=overall survival.